Edaravone plus compound cerebroside in elderly patients with carotid plaque cerebral infarction: Efficacy and prognosis
Edaravone, dextran and compound cerebroside combination therapy has a significant clinical effect on elderly CPMCI patients without reperfusion therapy, which can improve their functional independence, neurological function, activities of daily living and cognitive function, with acceptable safety.
Authors
- Wenbin Li (ORCID: https://orcid.org/0000-0001-7638-4395)
- Yidan Zhang (ORCID: https://orcid.org/0000-0001-6691-5244)
- Qi Dong
Institutions
- Harbin Medical University (CN)
- Sun Yat-sen University (CN)
- Fifth Affiliated Hospital of Sun Yat-sen University (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Clinical Neurology and Neurosurgery
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1016/j.clineuro.2025.109104
- Primary Topic
- Cerebrovascular and Carotid Artery Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00